Active Ingredient(s): Icatibant Acetate
FDA Approved: * August 25, 2011
Category: Immune System

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Firazyr Overview

Icatibant, trade name Firazyr, is medication that has been approved by the European Commission for the symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults with C1-esterase-inhibitor deficiency.[2] It is not effective in angioedema caused by medication from the ACE inhibitor class, as shown in a 2017 trial.[3] It is a peptidomimetic consisting of ten amino acids, which is a selective and specific antagonist of bradykinin B2 receptors....

Read more Firazyr Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Firazyr Forums: RSS Feed


Do you use Firazyr and Icatibant? ## Hi, Karen! How are you doing? Have you recently started treatment with it, or are you just looking for information on the drug? In the U.S. Firazyr has orphaned drug status. There really aren't a lot of Firazyr details available, but what I've found is at that link.


Possible Dosages for this and Related Drugs:

Icatibant Acetate
  • Injection: 30mg/3ml, 30mg/3ml (10mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Firazyr: (1 result)

Sorted by National Drug Code
  • 54092-702 Firazyr 30 mg/3ml Subcutaneous Injection, Solution by Shire Us Manufacturing Inc.

Other drugs which contain Icatibant Acetate or a similar ingredient: (1 result)

Related Firazyr Topics:

Do you use Firazyr and Icatibant? ## Hi, Karen! How are you doing? Have you recently started treatment with it, or are y... 1 reply

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA